CNBC Pro

Buying the right health care ETF as the industry races for a coronavirus cure or vaccine

John Davi, chief investment officer of Astoria Portfolio Advisors
Share
Spencer Platt | Getty Images

Everyone is wondering what needs to happen for life to get back a sense of normalcy amid the coronavirus pandemic.  It's pretty obvious — we need a vaccine and or a treatment.

There will be winners and losers in the race for a COVID-19 vaccine and treatment.  Just remember that investing in single stocks carries significantly more risk when compared to investing in a diversified portfolio of stocks such as an exchange-traded fund.

Here are some ETF options:

More In Pro News and Analysis

CNBC ProThese stocks reporting earnings in April are tactical trade candidates, Goldman says
CNBC ProOil demand is changing. These are the stocks that could benefit, says Goldman Sachs
CNBC ProThe set-up is 'attractive' for these stocks heading into earnings, analysts say